NMR and MD investigations of human galectin-1/oligosaccharide complexes.

PubWeight™: 0.85‹?›

🔗 View Article (PMC 2793364)

Published in Biophys J on December 16, 2009

Authors

Christophe Meynier1, Mikael Feracci, Marion Espeli, Florence Chaspoul, Philippe Gallice, Claudine Schiff, Françoise Guerlesquin, Philippe Roche

Author Affiliations

1: Unité Interactions et Modulateurs de Réponses, Institut de Microbiologie de la Méditerrannée, Centre National de la Recherche Scientifique, Marseille, France.

Articles cited by this

All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B (1998) 54.00

GLYCAM06: a generalizable biomolecular force field. Carbohydrates. J Comput Chem (2008) 4.51

Structural basis of lectin-carbohydrate recognition. Annu Rev Biochem (1996) 4.29

Oligosaccharide specificity of galectins: a search by frontal affinity chromatography. Biochim Biophys Acta (2002) 3.35

Galectin-1: a small protein with major functions. Glycobiology (2006) 3.06

Locally accessible conformations of proteins: multiple molecular dynamics simulations of crambin. Protein Sci (1998) 2.94

Galectins: structure, function and therapeutic potential. Expert Rev Mol Med (2008) 2.61

Introduction to galectins. Glycoconj J (2004) 2.30

X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution. J Biol Chem (1998) 1.99

Lectins: carbohydrate-specific reagents and biological recognition molecules. J Biol Chem (2007) 1.91

Galectins: matricellular glycan-binding proteins linking cell adhesion, migration, and survival. Cell Mol Life Sci (2007) 1.82

Carbohydrates as future anti-adhesion drugs for infectious diseases. Biochim Biophys Acta (2006) 1.75

The family of metazoan metal-independent beta-galactoside-binding lectins: structure, function and molecular evolution. Glycobiology (1993) 1.61

Growth-regulatory human galectin-1: crystallographic characterisation of the structural changes induced by single-site mutations and their impact on the thermodynamics of ligand binding. J Mol Biol (2004) 1.57

Lectins: tools for the molecular understanding of the glycocode. Org Biomol Chem (2005) 1.38

Crosslinking of mammalian lectin (galectin-1) by complex biantennary saccharides. Nat Struct Biol (1994) 1.30

Identification of common structural features of binding sites in galactose-specific proteins. Proteins (2004) 1.30

Expression of galectins in cancer: a critical review. Glycoconj J (2004) 1.28

Recent structural studies of carbohydrate-binding modules. Cell Mol Life Sci (2006) 1.26

Structural glycobiology: a game of snakes and ladders. Glycobiology (2008) 1.25

Tumor galectinology: insights into the complex network of a family of endogenous lectins. Glycoconj J (2004) 1.11

Human galectin-1 recognition of poly-N-acetyllactosamine and chimeric polysaccharides. Glycobiology (2003) 1.10

Deciphering the glycocode: the complexity and analytical challenge of glycomics. Curr Opin Chem Biol (2007) 1.09

Molecular dynamics simulations of galectin-1-oligosaccharide complexes reveal the molecular basis for ligand diversity. Proteins (2003) 1.09

An introduction to bioinformatics for glycomics research. PLoS Comput Biol (2008) 1.05

Anti-galectin compounds as potential anti-cancer drugs. Curr Med Chem (2006) 0.98

1H, 13C, and 15N backbone and side-chain chemical shift assignments for the 29 kDa human galectin-1 protein dimer. Biomol NMR Assign (2008) 0.96

Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer. Expert Opin Biol Ther (2008) 0.95

Structural analysis of the recognition mechanism of poly-N-acetyllactosamine by the human galectin-9 N-terminal carbohydrate recognition domain. Glycobiology (2008) 0.94

Thermodynamic binding studies of galectin-1, -3 and -7. Glycoconj J (2004) 0.92

Methodology for protein-ligand binding studies: application to a model for drug resistance, the HIV/FIV protease system. Proteins (1999) 0.84

Galectin-1 as a potential therapeutic agent for amyotrophic lateral sclerosis. Curr Drug Targets (2005) 0.82

Computational modeling of the sugar-lectin interaction. Adv Drug Deliv Rev (2004) 0.82

Galectins, galactoside-binding mammalian lectins: clinical application of multi-functional proteins. Acta Med Okayama (2001) 0.80

Conformational behaviour of glycomimetics: NMR and molecular modelling studies of the C-glycoside analogue of the disaccharide methyl beta-D-galactopyranosyl-(1-->3)-beta-D-glucopyranoside. Carbohydr Res (2007) 0.78

The conformation of the C-glycosyl analogue of N-acetyl-lactosamine in the free state and bound to a toxic plant agglutinin and human adhesion/growth-regulatory galectin-1. Carbohydr Res (2007) 0.77

Articles by these authors

Structures of three HIV-1 HLA-B*5703-peptide complexes and identification of related HLAs potentially associated with long-term nonprogression. J Immunol (2005) 1.60

Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I). Curr Opin Chem Biol (2011) 1.49

Solution structure of the E.coli TolA C-terminal domain reveals conformational changes upon binding to the phage g3p N-terminal domain. J Mol Biol (2005) 1.46

Follicular lymphoma-like B cells in healthy individuals: a novel intermediate step in early lymphomagenesis. J Exp Med (2006) 1.43

TRF2 promotes, remodels and protects telomeric Holliday junctions. EMBO J (2009) 1.42

Depletion of stromal cells expressing fibroblast activation protein-α from skeletal muscle and bone marrow results in cachexia and anemia. J Exp Med (2013) 1.40

Multiscaled exploration of coupled folding and binding of an intrinsically disordered molecular recognition element in measles virus nucleoprotein. Proc Natl Acad Sci U S A (2013) 1.34

Protein protein interaction inhibition (2P2I) combining high throughput and virtual screening: Application to the HIV-1 Nef protein. Proc Natl Acad Sci U S A (2007) 1.34

Atomic analysis of protein-protein interfaces with known inhibitors: the 2P2I database. PLoS One (2010) 1.29

Missense mutations in the homeodomain of HOXD13 are associated with brachydactyly types D and E. Am J Hum Genet (2003) 1.29

2P2Idb: a structural database dedicated to orthosteric modulation of protein-protein interactions. Nucleic Acids Res (2012) 1.25

Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc Natl Acad Sci U S A (2002) 1.25

Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements. Am J Hum Genet (2008) 1.12

Defective B-cell-negative selection and terminal differentiation in the ICF syndrome. Blood (2003) 1.05

Assessment of occupational exposure to welding fumes by inductively coupled plasma-mass spectroscopy and by the alkaline Comet assay. Environ Mol Mutagen (2006) 1.01

Galectin-1-expressing stromal cells constitute a specific niche for pre-BII cell development in mouse bone marrow. Blood (2011) 1.00

Clustering of pre-B cell integrins induces galectin-1-dependent pre-B cell receptor relocalization and activation. J Immunol (2006) 1.00

A new Groucho TLE4 protein may regulate the repressive activity of Pax5 in human B lymphocytes. Immunology (2002) 0.97

Osteoclast activity modulates B-cell development in the bone marrow. Cell Res (2011) 0.92

Basis of recognition between the NarJ chaperone and the N-terminus of the NarG subunit from Escherichia coli nitrate reductase. FEBS J (2010) 0.92

Structural and genetic analyses reveal a key role in prophage excision for the TorI response regulator inhibitor. J Biol Chem (2005) 0.90

Macromolecular import into Escherichia coli: the TolA C-terminal domain changes conformation when interacting with the colicin A toxin. Biochemistry (2002) 0.89

Initiation of pre-B cell receptor signaling: common and distinctive features in human and mouse. Semin Immunol (2005) 0.88

The involvement of CD146 and its novel ligand Galectin-1 in apoptotic regulation of endothelial cells. J Biol Chem (2012) 0.88

Non-nucleoside inhibitors of mitochondrial thymidine kinase (TK-2) differentially inhibit the closely related herpes simplex virus type 1 TK and Drosophila melanogaster multifunctional deoxynucleoside kinase. Mol Pharmacol (2003) 0.87

Impaired B-cell development at the pre-BII-cell stage in galectin-1-deficient mice due to inefficient pre-BII/stromal cell interactions. Blood (2009) 0.87

JAM-B regulates maintenance of hematopoietic stem cells in the bone marrow. Blood (2011) 0.86

Paracoccus pantotrophus pseudoazurin is an electron donor to cytochrome c peroxidase. Biochemistry (2004) 0.85

Germinal center reentries of BCL2-overexpressing B cells drive follicular lymphoma progression. J Clin Invest (2014) 0.85

Symbiotic and taxonomic diversity of rhizobia isolated from Acacia tortilis subsp. raddiana in Africa. Syst Appl Microbiol (2002) 0.85

GFscore: a general nonlinear consensus scoring function for high-throughput docking. J Chem Inf Model (2006) 0.85

Macrophage activation syndrome mimicking life-threatening infection in a patient with variable immunodeficiency, centromeric instability, and facial anomalies. Pediatrics (2004) 0.84

A new case of autosomal recessive agammaglobulinaemia with impaired pre-B cell differentiation due to a large deletion of the IGH locus. Eur J Pediatr (2002) 0.83

The NADP-reducing hydrogenase from Desulfovibrio fructosovorans: functional interaction between the C-terminal region of HndA and the N-terminal region of HndD subunits. Biochim Biophys Acta (2002) 0.83

Modeling study of human renal chloride channel (hCLC-5) mutations suggests a structural-functional relationship. Kidney Int (2003) 0.83

Conditional TPM3-ALK and NPM-ALK transgenic mice develop reversible ALK-positive early B-cell lymphoma/leukemia. Blood (2010) 0.83

Binding of free immunoglobulin light chains to VpreB3 inhibits their maturation and secretion in chicken B cells. J Biol Chem (2003) 0.83

Binding of p-cresylsulfate and p-cresol to human serum albumin studied by microcalorimetry. J Phys Chem B (2010) 0.82

The cytochrome c3-[Fe]-hydrogenase electron-transfer complex: structural model by NMR restrained docking. FEBS Lett (2003) 0.82

Synechocystis ferredoxin/ferredoxin-NADP(+)-reductase/NADP+ complex: Structural model obtained by NMR-restrained docking. FEBS Lett (2005) 0.82

Amplitude of pancreatic lipase lid opening in solution and identification of spin label conformational subensembles by combining continuous wave and pulsed EPR spectroscopy and molecular dynamics. Biochemistry (2010) 0.82

Modified cap group suberoylanilide hydroxamic acid histone deacetylase inhibitor derivatives reveal improved selective antileukemic activity. J Med Chem (2010) 0.82

The type I/type II cytochrome c3 complex: an electron transfer link in the hydrogen-sulfate reduction pathway. J Mol Biol (2005) 0.82

Validation of a rat seminiferous tubule culture model as a suitable system for studying toxicant impact on meiosis effect of hexavalent chromium. Toxicol Sci (2010) 0.81

The chemosensitivity to therapy of childhood early B acute lymphoblastic leukemia could be determined by the combined expression of CD34, SPI-B and BCR genes. Leuk Res (2005) 0.81

Galectin-1 is a powerful marker to distinguish chondroblastic osteosarcoma and conventional chondrosarcoma. Hum Pathol (2010) 0.81

Multiple orientations in a physiological complex: the pyruvate-ferredoxin oxidoreductase-ferredoxin system. Biochemistry (2004) 0.81

Computational studies of human galectin-1: role of conserved tryptophan residue in stacking interaction with carbohydrate ligands. J Biomol Struct Dyn (2009) 0.80

Influence of the length of imogolite-like nanotubes on their cytotoxicity and genotoxicity toward human dermal cells. Chem Res Toxicol (2012) 0.80

2P2I HUNTER: a tool for filtering orthosteric protein-protein interaction modulators via a dedicated support vector machine. J R Soc Interface (2013) 0.80

Galectin 1 modulates plasma cell homeostasis and regulates the humoral immune response. J Immunol (2013) 0.80

Protein-protein interaction inhibition (2P2I): fewer and fewer undruggable targets. Comb Chem High Throughput Screen (2009) 0.80

An integrative in silico methodology for the identification of modulators of macrophage migration inhibitory factor (MIF) tautomerase activity. Bioorg Med Chem (2010) 0.79

The crystal structure of the hexadeca-heme cytochrome Hmc and a structural model of its complex with cytochrome c(3). Structure (2002) 0.79

Focused chemical libraries--design and enrichment: an example of protein-protein interaction chemical space. Future Med Chem (2014) 0.79

Reply to Jensen and Blackledge: Dual quantifications of intrinsically disordered proteins by NMR ensembles and molecular dynamics simulations. Proc Natl Acad Sci U S A (2014) 0.78

TM0486 from the hyperthermophilic anaerobe Thermotoga maritima is a thiamin-binding protein involved in response of the cell to oxidative conditions. J Mol Biol (2010) 0.78

Structural and mechanistic insights into unusual thiol disulfide oxidoreductase. J Biol Chem (2011) 0.78

Role of the tetrahemic subunit in Desulfovibrio vulgaris hildenborough formate dehydrogenase. Biochemistry (2005) 0.77

1H, 13C and 15N backbone and side-chain chemical shift assignments for oxidized and reduced desulfothioredoxin. Biomol NMR Assign (2010) 0.77

Structural basis for galectin-1-dependent pre-B cell receptor (pre-BCR) activation. J Biol Chem (2012) 0.77

Structural analysis of the HiPIP from the acidophilic bacteria: Acidithiobacillus ferrooxidans. Extremophiles (2006) 0.76

Interaction and electron transfer between the high molecular weight cytochrome and cytochrome c3 from Desulfovibrio vulgaris Hildenborough: kinetic, microcalorimetric, EPR and electrochemical studies. Biochim Biophys Acta (2005) 0.76

Evaluation of a battery of Salmonella typhimurium tester strains for biomonitoring of mutagenic polycyclic aromatic hydrocarbons, nitroarenes and aromatic amines. Mutat Res (2006) 0.76

Ex-vivo assessment of chronic toxicity of low levels of cadmium on testicular meiotic cells. Toxicol Appl Pharmacol (2012) 0.76

Examination of galectin-induced lattice formation on early B-cell development. Methods Mol Biol (2015) 0.76

Solution structure of HndAc: a thioredoxin-like domain involved in the NADP-reducing hydrogenase complex. Protein Sci (2006) 0.75

Sequential NMR assignment of the ferri-cytochrome c3 from Desulfovibrio vulgaris Hildenborough. J Biomol NMR (2002) 0.75

1H, 13C and 15N chemical shift assignments of the thioredoxin from the obligate anaerobe Desulfovibrio vulgaris Hildenborough. Biomol NMR Assign (2011) 0.75

Stereoselective synthesis of original spirolactams displaying promising folded structures. Org Biomol Chem (2013) 0.75

MEMO associated with an ErbB2 receptor phosphopeptide reveals a new phosphotyrosine motif. FEBS Lett (2011) 0.75

Increased red cell turnover in a line of CD22-deficient mice is caused by Gpi1c: a model for hereditary haemolytic anaemia. Eur J Immunol (2012) 0.75

[Galectin-1 is a ligand for the pre-B cell receptor]. Med Sci (Paris) (2003) 0.75